NCT03814343View on ClinicalTrials.gov

Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

November 15, 2020

Study Completion Date

November 30, 2020

Conditions
Fungal InfectionOnychomycosisFungus, Nail
Interventions
DRUG

amphotericin B in 30% DMSO

amphotericin B in 30% DMSO was given to patients in active comparators group for continuous 12 weeks.

DRUG

30% DMSO

30% DMSO was given to patients in placebo comparators group for continuous 12 weeks.

Trial Locations (1)

10700

Department of Dermatology Siriraj Hospital, Bangkoknoi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT03814343 - Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis | Biotech Hunter | Biotech Hunter